title: Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.
abstract: An outbreak of nosocomial fungemia due to the unusual yeast, Pichia anomala occurred in the pediatric wards of our hospital over a period of 23 months (April 1996 to February 1998). A total of 379 neonates and children (4.2% admissions) were infected. The probable index case was admitted to the pediatric emergency ward, with subsequent transmission to the premature nursery, pediatric intensive care units, and other children wards. Carriage on the hands of health care personnel was likely to be responsible for dissemination of the fungus. The outbreak could only be controlled after a health education campaign to improve hand-washing practices was instituted and after nystatin-fluconazole prophylaxis to all premature neonates and high-risk infants was introduced. In a case-control study, we identified a lower gestational age, a very low birth weight (<1,500 g), and a longer duration of hospital stay as significant risk factors associated with P. anomala fungemia in premature neonates. We conducted a culture prevalence survey of 50 consecutive premature neonates and found that 28% were colonized with P. anomala at a skin or mucosal site on the date of delivery and that 20% of these neonates subsequently developed P. anomala fungemia. We performed multilocus enzyme electrophoresis on 40 P. anomala outbreak isolates (including patient and health care workers' hand isolates), and the results suggested that these isolates were identical. Our study highlights the importance of P. anomala as an emerging nosocomial fungal pathogen.
authors.affiliation: Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. medinst@pgi.nic.in
authors.forename: A
authors.initials: A
authors.lastname: Chakrabarti
authors.forename: K
authors.initials: K
authors.lastname: Singh
authors.forename: A
authors.initials: A
authors.lastname: Narang
authors.forename: S
authors.initials: S
authors.lastname: Singhi
authors.forename: R
authors.initials: R
authors.lastname: Batra
authors.forename: K L
authors.initials: KL
authors.lastname: Rao
authors.forename: P
authors.initials: P
authors.lastname: Ray
authors.forename: S
authors.initials: S
authors.lastname: Gopalan
authors.forename: S
authors.initials: S
authors.lastname: Das
authors.forename: V
authors.initials: V
authors.lastname: Gupta
authors.forename: A K
authors.initials: AK
authors.lastname: Gupta
authors.forename: S M
authors.initials: SM
authors.lastname: Bose
authors.forename: M M
authors.initials: MM
authors.lastname: McNeil
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology; D016022:Case-Control Studies; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D004196:Disease Outbreaks; D005260:Female; D016469:Fungemia / Q000453:epidemiology* / Q000382:microbiology; D006225:Hand / Q000382:microbiology; D006761:Hospitals; D006801:Humans; D007194:India / Q000453:epidemiology; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000382:microbiology; D008297:Male; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000453:epidemiology* / Q000382:microbiology; D010372:Pediatrics; D010843:Pichia / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D012307:Risk Factors; D012867:Skin / Q000382:microbiology
chemical_list: D000935:Antifungal Agents